Trial intelligence / Profile preview

Ligation vs Propranolol for Primary Prophylaxis of Variceal Bleeding in Liver Transplant Candidates

NCT00337740Phase 3Terminated

Sponsor
Università di Padova
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of propranolol in esophageal varices (2 arms), sponsored by Università di Padova. Primary endpoint: Incidence of Variceal Bleeding. Status: terminated.

02

Drugs

propranolol
03

Conditions

esophageal varices

Beyond the preview

Go deeper on NCT00337740.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00337740.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call